Lavanya Bellumkonda, MD
Associate Professor of Medicine (Cardiovascular Medicine)Cards
About
Research
Publications
2026
Working Toward a More Environmentally Sustainable Echocardiography Lab: Present Considerations and Future Directions.
Chang AY, Bellumkonda L, McNamara RL, Yao Y, Zoghbi WA, Rajagopalan S, Al-Kindi S. Working Toward a More Environmentally Sustainable Echocardiography Lab: Present Considerations and Future Directions. J Am Soc Echocardiogr 2026 PMID: 42731736, DOI: 10.1016/j.echo.2026.08.025.Commentaries, Editorials and LettersDiscordance of Aortic Valve Area Indexed to Actual and Ideal Body Surface Area in Aortic Stenosis
Reinhardt S, Singh J, Shah N, McNamara R, Sugeng L, Agarwal V, Hur D, Lombo B, Bellumkonda L, Akintoye E, Shkolnik E, Velazquez E, Faridi K. Discordance of Aortic Valve Area Indexed to Actual and Ideal Body Surface Area in Aortic Stenosis. Journal Of The American Society Of Echocardiography 2026 PMID: 41997251, DOI: 10.1016/j.echo.2026.03.013.Peer-Reviewed Original ResearchCoronary calcifications and myocardial flow reserve in heart transplant patients: a longitudinal study
Wright C, Kiage J, Kyriakoulis I, Csecs I, Ahmed A, Tong G, Zeng Y, Liu Y, Bellumkonda L, Kokkinidis D, Sinusas A, Miller E, Feher A. Coronary calcifications and myocardial flow reserve in heart transplant patients: a longitudinal study. European Heart Journal 2026, 47: 3214-3216. PMID: 41780909, DOI: 10.1093/eurheartj/ehag163.Peer-Reviewed Original Research3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension
Bellumkonda L, Sugeng L, Joseph P, Kundu P, Izzi D, Zalik F, McCabe S, Raza A, Amendola R, Heerdt P, Hunter K, Singh I. 3D echo derived right ventricular principal surface strain in pulmonary arterial hypertension. AJP Heart And Circulatory Physiology 2026, 330: h729-h736. PMID: 41616802, PMCID: PMC13097151, DOI: 10.1152/ajpheart.00923.2025.Peer-Reviewed Original ResearchThe environmental exposome in heart failure risk and progression
Hahad O, Wass S, Rajagopalan S, Abohashem S, Hao H, Navas-Acien A, Bellumkonda L, Chen K, Brook R, Nasir K, Lurz P, Lanfear D, Bhimaraj A, Al-Kindi S. The environmental exposome in heart failure risk and progression. Nature Reviews Cardiology 2026, 23: 457-472. PMID: 41582253, DOI: 10.1038/s41569-026-01247-1.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsClinical outcomes of aortic stenosis patients undergoing Impella-supported high-risk percutaneous coronary intervention
Velagapudi P, Bellumkonda L, Cohen D, Lansky A, Abu-Much A, Thompson J, Schonning M, Redfors B, Zhou Z, Grines C, Maini A, Li Y, Batchelor W, O’Neill W. Clinical outcomes of aortic stenosis patients undergoing Impella-supported high-risk percutaneous coronary intervention. Frontiers In Cardiovascular Medicine 2026, 12: 1638259. PMID: 41573507, PMCID: PMC12819752, DOI: 10.3389/fcvm.2025.1638259.Peer-Reviewed Original Research
2025
Air Pollution and Exposomic Impacts on Heart Failure
Bellumkonda L, Khawaja T, Al-Kindi S, Khraishah H, Rajagopalan S. Air Pollution and Exposomic Impacts on Heart Failure. Circulation Heart Failure 2025, 19: e013338. PMID: 41347303, DOI: 10.1161/circheartfailure.125.013338.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsLoop Diuretic Dose Intensification versus Adjuvant Thiazide for Diuretic Resistance in Acute Heart Failure
Rao V, Cox Z, Ivey-Miranda J, Moreno-Villagomez J, Ramos-Mastache D, Maulion C, Bellumkonda L, Turner J, Wilson F, Shilpak M, Estrella M, Welling P, Wilcox C, Ellison D, Forbush B, Testani J. Loop Diuretic Dose Intensification versus Adjuvant Thiazide for Diuretic Resistance in Acute Heart Failure. Journal Of The American Society Of Nephrology 2025, 37: 533-544. PMID: 40938670, PMCID: PMC12935386, DOI: 10.1681/asn.0000000887.Peer-Reviewed Original ResearchSCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women.
Baron S, Chou J, Shah T, Vest A, Abbott J, Alasnag M, Aurigemma C, Barbato E, Bellumkonda L, Bortnick A, Chieffo A, van Geuns R, Grines C, Halvorsen S, Hassager C, Kapur N, Naidu S, Ng V, Saw J, Lansky A. SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women. EuroIntervention 2025, 21: 894-909. PMID: 40387531, PMCID: PMC12337771, DOI: 10.4244/eij-d-24-01126.Peer-Reviewed Original ResearchWealth and Mortality in the United States and Europe.
Bellumkonda L. Wealth and Mortality in the United States and Europe. The New England Journal Of Medicine 2025, 393: 206. PMID: 40632967, DOI: 10.1056/nejmc2506058.Commentaries, Editorials and Letters
Clinical Trials
Current Trials
Ertugliflozin in Acute Heart Failure
IRB ID2000027951RoleSub InvestigatorPrimary Completion Date01/31/2022Recruiting ParticipantsGenderBothAge18+ yearsTranscatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO)
IRB ID2000021883RoleSub InvestigatorPrimary Completion Date10/31/2021Recruiting ParticipantsGenderBothAge18+ years
Academic Achievements & Community Involvement
Clinical Care
Overview
As a cardiologist who specializes in advanced heart failure and transplantation, Lavanya Bellumkonda, MD, says offering hope is key when she first meets a patient.
“When someone hears the term ‘heart failure,’ they may think they are dying imminently. I first review the severity of their disease and try to set realistic expectations. A number of patients with heart failure will have improvement in their cardiac function with appropriate medical therapy,” she explains. “If their disease is advanced, they may need a mechanical pump to assist the heart or a heart transplantation, and we discuss the success rates and risks associated with each of these strategies.”
Heart failure describes any kind of dysfunction in the heart that causes a build-up of fluids, resulting in shortness of breath, fatigue, and swelling in the legs. Dr. Bellumkonda says she was drawn to her field because of her fascination with the physiology of the heart and the acuity of cardiac illnesses.
“What I also like about transplant cardiology is that you get to apply all that you learnt in medicine and cardiology,” she says. “Post-transplant, patients often rely on me to manage their medical conditions as well.”
Additionally, Dr. Bellumkonda treats patients with valve disease. “The most common valves affected are the mitral or aortic valves, where these valves get either too tight or too leaky, causing symptoms similar to heart failure,” she says. “At Yale, we treat these patients in a multidisciplinary fashion and provide appropriate recommendations regarding catheter-based interventions and surgery.”
Her research interests include cardiac recovery and cardio-renal reactions in patients with valve disease. “What makes me most happy in my work is when I have cardiac recovery in my patients, meaning they have an improvement in their heart function,” she says. “That makes me feel like I have done my job.”
Clinical Specialties
Fact Sheets
Ventricular Assist Device (VAD)
Learn More on Yale MedicineCongestive Heart Failure (CHF)
Learn More on Yale MedicineExtracorporeal Membrane Oxygenation (ECMO)
Learn More on Yale MedicineHeart Failure Surgery
Learn More on Yale Medicine
Yale Medicine News
News
News
Get In Touch
Contacts
Cardiovascular Medicine
333 Cedar St., PO Box 20817
New Haven, CT 06520
United States
Locations
Patient Care Locations
Are You a Patient? View this doctor's clinical profile on the Yale Medicine website for information about the services we offer and making an appointment.